Therefore, further preclinical studies are warranted to evaluate the effect of BAFF-R specific antibodies on PCNSL, preferentially in combination with methotrexate-based chemotherapy. The gene discussed is TNFRSF13C; the disease is primary central nervous system lymphoma.